Pulsatile luteinizing hormone amplitude and progesterone metabolite excretion are reduced in obese women.
J. Clin. Endocrinol. Metab., Jul;92(7):2468-73 (2007)
Estradiol and progesterone modify the effects of the serotonin reuptake transporter polymorphism on serotonergic responsivity to citalopram.
Exp Clin Psychopharmacol., Dec;19(6):401-8 (2011)
Current status of the approach to assisted reproduction.
Pediatr. Clin. North Am., Jun;56(3):467-88, Table of Contents (2009)
Athletic amenorrhea: energy deficit or psychogenic challenge?
Ann. N. Y. Acad. Sci., Sep;1205:33-8 (2010)
Increased ghrelin sensitivity and calorie consumption in subordinate monkeys is affected by short-term astressin B administration.
Endocrine., Oct;38(2):227-34 (2010)
The diagnosis and treatment of stress-induced anovulation.
Minerva Ginecol., Feb;57(1):45-54 (2005)
Increased cortisol in the cerebrospinal fluid of women with functional hypothalamic amenorrhea.
J. Clin. Endocrinol. Metab., Apr;91(4):1561-5 (2006)
Use of cognitive behavior therapy for functional hypothalamic amenorrhea.
Ann. N. Y. Acad. Sci., Dec;1092:114-29 (2006)
Stress and reprodution: a tale of false dichotomy?
Endocrinology., Mar;149(3):867-8 (2008)
Impairment of ovarian function and associated health-related abnormalities are attributable to low social status in premenopausal monkeys and not mitigated by a high-isoflavone soy diet.
Hum. Reprod., Dec;25(12):3083-94 (2010)
The obstetrician-gynecologist's role in the practical management of polycystic ovary syndrome.
Am. J. Obstet. Gynecol., Dec;179(6 Pt 2):S109-S113 (1998)
The feasibility of long-term treatment of polycystic ovary syndrome with GnRH-agonists.
J. Endocrinol. Invest., Oct;21(9):630-1 (1998)
Ovarian responses in women to recombinant follicle-stimulating hormone and luteinizing hormone (LH): a role for LH in the final stages of follicular maturation.
J. Clin. Endocrinol. Metab., Jan;84(1):228-32 (1999)
Cerebrospinal fluid levels of corticotropin-releasing hormone in women with functional hypothalamic amenorrhea.
Am. J. Obstet. Gynecol., Apr;182(4):776-81; discussion 781-4 (2000)
Do polycystic-appearing ovaries affect the risk of cardiovascular disease among women with polycystic ovary syndrome?
Fertil. Steril., Sep;74(3):547-52 (2000)
Systemic benefits of cyclic ovarian function.
J. Soc. Gynecol. Investig., 8(1 Suppl Proceedings):S3-6 (2001)
Neuromodulation in polycystic ovary syndrome.
Obstet. Gynecol. Clin. North Am., Mar;28(1):35-62 (2001)
Endocrine and chronobiological effects of fasting in women.
Fertil. Steril., May;75(5):926-32 (2001)
Role of GnRH drive in the pathophysiology of polycystic ovary syndrome.
J. Endocrinol. Invest., 21(7):476-85 (1998)
Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study.
J Clin Epidemiol., May;51(5):415-22 (1998)